Saving Medicare through Patient-Centered Changes — The Case of Injectables

Medicare covers the cost of injectable drugs only when they're administered in a hospital or physician's office, but considerations of convenience, cost, and quality all argue for encouraging patients to participate in their own care by allowing self-administration. As we debate Medicare&#...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 368; no. 17; pp. 1572 - 1573
Main Authors Farroni, Jeffrey S, Zwelling, Leonard, Cortes, Jorge, Kantarjian, Hagop
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 25.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Medicare covers the cost of injectable drugs only when they're administered in a hospital or physician's office, but considerations of convenience, cost, and quality all argue for encouraging patients to participate in their own care by allowing self-administration. As we debate Medicare's solvency and the ever-rising cost of health care and health insurance, it makes sense to examine easily implementable policies that will reduce costs. Total Medicare expenditures were $549 billion in 2011. 1 Pursuing more prudent (though perhaps less than ideal) policies, such as those in place in Canada, might have saved over $2 trillion between 1980 and 2009. 2 Ideally, we would find ways to reduce costs without harming beneficiaries, so the $716 billion “cut” to Medicare under the Affordable Care Act (ACA) actually represents savings to be achieved over a 10-year period from anticipated reductions in payments . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMp1213485